Last 3.26 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 5:00 AM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

pharmaids pharmaceuticals lt (PHAD) Snapshot

Open
3.26
Previous Close
3.26
Day High
3.26
Day Low
3.26
52 Week High
06/25/14 - 4.36
52 Week Low
12/31/14 - 2.05
Market Cap
11.1M
Average Volume 10 Days
10.0
EPS TTM
-0.32
Shares Outstanding
3.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMAIDS PHARMACEUTICALS LT (PHAD)

Related News

No related news articles were found.

pharmaids pharmaceuticals lt (PHAD) Related Businessweek News

No Related Businessweek News Found

pharmaids pharmaceuticals lt (PHAD) Details

Pharmaids Pharmaceuticals Limited produces and markets pharmaceutical formulations in India. It offers allopathic, herbal ayurvedic, and natural drug formulations in various forms, such as tablets, capsules, liquids, powders, etc. The company was incorporated in 1989 and is based in Hyderabad, India.

Founded in 1989

pharmaids pharmaceuticals lt (PHAD) Top Compensated Officers

Chairman, Managing Director, Chairman of Remu...
Total Annual Compensation: 150.0K
Executive Director and Member of Stock Holder...
Total Annual Compensation: 72.0K
Compensation as of Fiscal Year 2014.

pharmaids pharmaceuticals lt (PHAD) Key Developments

Pharmaids Pharmaceuticals Ltd., Board Meeting, Feb 14, 2015

Pharmaids Pharmaceuticals Ltd., Board Meeting, Feb 14, 2015. Agenda: To consider quarterly results.

Pharmaids Pharmaceuticals Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Pharmaids Pharmaceuticals Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net sales/income from operations of INR 4.529 million against INR 2.838 million a year ago. Loss from operations before other income, finance costs & exceptional items was INR 0.263 million against INR 0.001 million a year ago. Profit from ordinary activities before tax was INR 0.232 million against INR 0.285 million a year ago. Net profit for the period was INR 0.232 million against INR 0.285 million a year ago. Basic and diluted earnings per share were INR 0.07 against INR 0.08 a year ago. For the six months, the company reported net sales/income from operations of INR 9.046 million against INR 5.551 million a year ago. Loss from operations before other income, finance costs & exceptional items was INR 0.847 million against INR 0.253 million a year ago. Profit from ordinary activities before tax was INR 0.406 million against INR 0.466 million a year ago. Net profit for the period was INR 0.406 million against INR 0.466 million a year ago. Basic and diluted earnings per share were INR 0.12 against INR 0.14 a year ago.

Pharmaids Pharmaceuticals Ltd., Board Meeting, Nov 15, 2014

Pharmaids Pharmaceuticals Ltd., Board Meeting, Nov 15, 2014. Agenda: To consider unaudited standalone earnings results for the second quarter and six months ended September 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHAD:IN 3.26 INR 0.00

PHAD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHAD.
View Industry Companies
 

Industry Analysis

PHAD

Industry Average

Valuation PHAD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.7x
Price/Book 0.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMAIDS PHARMACEUTICALS LT, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.